UK markets open in 2 hours 40 minutes
NIKKEI 225
28,780.76 -79.86 (-0.28%) HANG SENG
24,220.29 +223.42 (+0.93%) CRUDE OIL
73.05 +0.69 (+0.95%) GOLD FUTURES
1,786.20 +0.70 (+0.04%) DOW
35,754.75 +35.32 (+0.10%) BTC-GBP
37,687.37 -641.00 (-1.67%)
Hikma Pharmaceuticals PLC (HIK.L)
LSE - LSE Delayed price. Currency in GBp
Add to watchlist
At close: 04:35PM GMT
| Previous close | 2,266.00 |
| Open | 2,275.00 |
| Bid | 2,258.00 x 0 |
| Ask | 2,260.00 x 0 |
| Day's range | 2,249.00 - 2,288.00 |
| 52-week range | 2,158.00 - 2,703.00 |
| Volume | |
| Avg. volume | 412,758 |
| Market cap | 5.248B |
| Beta (5Y monthly) | -0.09 |
| PE ratio (TTM) | 14.96 |
| EPS (TTM) | 151.50 |
| Earnings date | 24 Feb 2022 |
| Forward dividend & yield | 0.38 (1.66%) |
| Ex-dividend date | 19 Aug 2021 |
| 1y target est | 27.77 |
- Simply Wall St.
Those who invested in Hikma Pharmaceuticals (LON:HIK) five years ago are up 62%
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...
- Simply Wall St.
Declining Stock and Solid Fundamentals: Is The Market Wrong About Hikma Pharmaceuticals PLC (LON:HIK)?
Hikma Pharmaceuticals (LON:HIK) has had a rough month with its share price down 8.0%. However, a closer look at its...
- Zacks
Hikma Pharmaceuticals Plc (HKMPF) Moves to Buy: Rationale Behind the Upgrade
Hikma Pharmaceuticals Plc (HKMPF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
© 2021 Yahoo. All rights reserved.
